Why insider trading matters?

When insiders buy shares on the open market, this can thus be regarded as a strong endorsement by those that know the company the best -- they are literally betting their own money on the company's future. Insider selling, however, is not necessarily meaningful in any way, as there is a range of reasons for insiders to liquidate (some) of the shares they own.

- Seeking Alpha
FATE THERAPEUTICS INC (FATE)
Sector: Healthcare; Industry: Biotechnology

Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. The company's NK- and T-cell immuno-oncology programs under development also includes ProTmune for the treatment of hematologic malignancies; FATE-NK100 for the treatment of recurrent ovarian cancer; and FATE-NK100 for the treatment of advanced solid tumors.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-01-22 Wolchko J Scott President and CEO Sell 60,000 $100.67 $6,039,968 Yes
2021-01-19 TAHL CINDY General Counsel and Secretary Sell 35,000 $114.76 $4,016,639 Yes
2021-01-11 Wolchko J Scott President and CEO Sell 69,407 $116.33 $8,073,772 No
2021-01-11 Valamehr Bahram Chief Development Officer Sell 9,484 $114.95 $1,090,140 No
2021-01-11 TAHL CINDY General Counsel and Secretary Sell 9,483 $114.94 $1,090,021 No
2021-01-11 Shoemaker Daniel D Chief Scientific Officer Sell 9,482 $114.95 $1,089,911 No
2021-01-08 Redmile Group, LLC 10%-Owner, Director Buy 327,485 $85.50 $27,999,968 Yes
2020-12-17 Wolchko J Scott President and CEO Sell 20,000 $91.82 $1,836,352 Yes
2020-12-14 Valamehr Bahram Chief Development Officer Sell 25,000 $97.78 $2,444,477 Yes
2020-11-16 Shoemaker Daniel D Chief Scientific Officer Sell 25,000 $51.83 $1,295,746 No
2020-11-13 Wolchko J Scott President and CEO Sell 60,000 $51.87 $3,112,424 Yes
2020-11-05 TAHL CINDY General Counsel and Secretary Sell 70,801 $50.47 $3,573,392 Yes
2020-10-16 TAHL CINDY General Counsel and Secretary Sell 29,199 $50.25 $1,467,212 Yes
2020-10-01 TAHL CINDY General Counsel and Secretary Sell 35,000 $40.74 $1,426,065 Yes
2020-09-14 Valamehr Bahram Chief Development Officer Sell 25,000 $36.28 $907,024 Yes
2020-09-14 Shoemaker Daniel D Chief Scientific Officer Sell 25,000 $36.30 $907,540 No
2020-06-11 Redmile Group, LLC 10%-Owner, Director Buy 1,412,928 $28.31 $39,999,992 No
2020-01-30 Wolchko J Scott President and CEO Sell 25,000 $25.45 $636,302 Yes
2020-01-08 Valamehr Bahram Chief Development Officer Sell 5,700 $20.69 $117,947 Yes
2020-01-08 TAHL CINDY General Counsel and Secretary Sell 5,700 $20.72 $118,085 Yes
2020-01-08 Shoemaker Daniel D Chief Scientific Officer Sell 5,700 $20.70 $117,986 Yes
2019-12-30 Shoemaker Daniel D Chief Scientific Officer Sell 25,000 $19.50 $487,427 Yes
2019-12-20 Wolchko J Scott President and CEO Sell 50,000 $20.12 $1,006,055 Yes
2019-10-15 Wolchko J Scott President and CEO Sell 21,017 $14.44 $303,458 No
2019-10-15 Valamehr Bahram Chief Development Officer Sell 6,200 $14.18 $87,891 No
2019-10-15 TAHL CINDY General Counsel and Secretary Sell 10,200 $14.24 $145,292 No
2019-10-15 Shoemaker Daniel D Chief Scientific Officer Sell 11,800 $14.29 $168,592 No
2019-09-16 Redmile Group, LLC 10%-Owner, Director Buy 857,143 $17.50 $15,000,002 No
2019-08-01 Nashat Amir Director Sell 62,005 $22.53 $1,397,066 No
2019-07-30 Nashat Amir Director Sell 118,333 $22.51 $2,663,115 No

Insider Smart

PROSPECT CAPITAL CORP (PSEC) - PSEC is the 2nd most bought stock of the past 90 days by insiders, CEO seems very confident about the company.

Insider Smart

Enphase Energy, Inc (ENPH) - Watch for CEO Kothandaraman Badrinarayanan and CFO Branderiz Eric, their trading have a good pattern you can't miss, very well timed buy low and sell high.